Glassman Wealth Services Aerie Pharmaceuticals Inc Transaction History

Glassman Wealth Services

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$17.72 - $25.1 $726 - $1,029	-41 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$18.41 - $28.0 $644 - $980	35 Added 583.33%	41 $1,000
Q2 2019 Aug 08, 2019	SELL	$28.97 - $48.21 $202 - $337	-7 Reduced 53.85%	6 $0
Q1 2019 May 10, 2019	BUY	$36.32 - $49.25 $472 - $640	13 New	13 $1,000
Q1 2018 May 01, 2018	SELL	$51.15 - $61.0 $204 - $244	-4 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$50.85 - $65.1 $203 - $260	4	4 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.